baber/WOPTO huggingface dataset:
Patent FI-862755-A0 (FI)
Inventor: KLEINE-DOEPKE WOLFGANG
IPC: B32B17/10
Filed: 1986-06-27
Abstract: For production of a composite glass pane from at least one silicate glass pane and at least one layer of a transparent plastics material, the plastics layer is glued to the glass pane by means of an UV-hardening adhesive. A homogeneous solution of photopolymerizable acrylic monomers (component A), a polymer (component B) and a photoinitiator (component C) is used as the adhesive, wherein the component (A) consists of a mixture of at least one  alpha ,  beta -unsaturated carboxylic acid and at least one monofunctional  alpha , beta -unsaturated carboxylic acid ester of an alcohol comprising 2 to 10 C-atoms, possibly comprising also oxygen atoms in the form of ether groups and/or hydroxyl groups, and component (B) consists of a polymer composed entirely or predominantly of vinyl chloride, which polymer is possibly after-chlorinated.
Patent FI-874292-A0 (FI)
Inventor: DIETRICH WOLF
IPC: B27K3/12
Filed: 1987-09-30
Abstract: A novel suspension of boric acid comprising a concentrated, finely dispersed suspension of boric acid and a small amount of a soluble borate salt in an aqueous medium and a method of preparing the same.
Patent FI-913617-A0 (FI)
Inventor: DAVIS ROBERT BERNARD
IPC: D21F7/08
Filed: 1991-07-29
Abstract: PCT No. PCT/GB90/01846 Sec. 371 Date Sep. 19, 1991 Sec. 102(e) Date Sep. 19, 1991 PCT Filed Nov. 28, 1990 PCT Pub. No. WO91/08340 PCT Pub. Date Jun. 13, 1991.The present invention relates to a felt for use in papermaking machines showing enhanced resistance to degradation in the presence of peroxide which felt comprises a woven base and a sheet contracting layer attached thereto characterized in that at least one of said layer and said woven base comprises fibers of polyamide 12, 12 found by extrusion of a melt of polyamide 12, 12 having intrinsic viscosity of not less than 0.65 dl/gram.
Patent FI-922165-A0 (FI)
Inventor: VIDAL SUSAN M
IPC: A23L1/00
Filed: 1992-05-13
Abstract: A new and useful calcium salt of citric acid is prepared and is used as an anticaking agent in furctose-sweetened powdered soft drinks. Also included are the processes for preparing the new calcium salt and powdered beverage mixes containing the new salt.
Patent FI-925901-A0 (FI)
Inventor: SVENSSON KARIN BIRTE
IPC: C12P19/20
Filed: 1992-12-28
Abstract: A process for converting starch or partially hydrolyzed starch into a syrup containing dextrose includes the steps of saccharifying starch hydrolyzate in the presence of a saccharifying starch hydrolyzate in the presence of a mutated glucoamylase or related enzyme and increasing the selectivity of the enzyme for  alpha -(1->4)-glucosidic bonds by the glucoamylase or related enzyme by including at least one mutation, the mutation substituting an amino acid of the enzyme with at least one amino acid chosen by comparison with structurally related regions of other enzymes that selectively hydrolyze only  alpha -(1->4) glucosidic bonds. Enzymes made in accordance with the present invention are also disclosed.
Patent FI-941400-A0 (FI)
Inventor: FRANCIS DEBRA CAROL
IPC: B29C48/13
Filed: 1994-03-25
Abstract: PCT No. PCT/US91/06899 Sec. 371 Date Mar. 22, 1994 Sec. 102(e) Date Mar. 22, 1994 PCT Filed Sep. 27, 1991 PCT Pub. No. WO93/05946 PCT Pub. Date Apr. 1, 1993.Composite coatings are provided having a variable thickness and a gradient coloration in the cross-web direction using a premetered extrusion coating process wherein a pigmented coating composition and a non-pigmented coating composition are simultaneously extruded onto a carrier film. The composite coatings are useful in preparing laminated structures such as automobile windshields with a colored gradient band.
Patent FI-942812-A0 (FI)
Inventor: HOUSE MARSHALL K
IPC: B66F9/18
Filed: 1994-06-14
Abstract: A load-handling parallel arm clamp structure (10) for a lift truck comprises a slide guide frame (14) having respective upper and lower pairs of elongate, parallel, vertically-spaced transverse slide guides (20, 22) with load-arm supporting slide members (26, 28) longitudinally movable thereon alternatively toward or away from one another in a mutually overlapping longitudinal relationship. Each slide member (26, 28) at least partially surrounds the respective slide guide (20, 22) upon which it is mounted, and each slide guide in turn at least partially surrounds a respective piston and cylinder assembly (44, 46) for moving the slides relative to the guides. The upper and lower pairs of guides (20, 22) are separated by a wide, unobstructed central vertical space through which the operator can view in a forward direction, such space being unoccupied by any view-impeding piston and cylinder assemblies due to their placement inside the guides. A compact fluid manifold (54) and valve arrangement (56) for controlling the piston and cylinder assemblies, together with the space-saving cylinder-enclosing slide guides (20, 22), minimize the thickness of the entire assembly in the forward direction to maximize load-carrying capacity compatibly with the high degree of operator visibility provided. <IMAGE>
Patent FI-943392-A0 (FI)
Inventor: POWELL DENNIS
IPC: C07C323/60
Filed: 1994-07-15
Abstract: Compounds of the general formula: <CHEM> wherein R1, R2, R3, R4 and R5 are herein described, A is a straight or branched (C2-C12)alkyl or a phenyl moiety and B is a moiety of the formula: <CHEM> The compounds are effective in potentiating the activity of chemotherapeutic anti-cancer agents by increasing the sensitivity of multi-drug resistant cells to such chemotherapeutic agents.
Patent FI-954299-A0 (FI)
Inventor: HOLTEY THOMAS O
IPC: G06F21/85
Filed: 1995-09-13
Abstract: An application memory card system includes a secure memory card which can be operatively connected to communicate with a host mainframe microprocessor or hand held device host microprocessor via a standard interface. The secure memory card contains an application processor and an access control microprocessor (ACP), each of which connect through an internal bus to a number of non-volatile addressable memory chips, each organized into a plurality of blocks. Each microprocessor has an additional control signal line included in a control bus portion of its bus for specifying "Execute" access. An access discrimination logic unit which connects to the internal bus and to the non-volatile memory includes an access by type memory writable by the application processor under the control of the ACP for maintaining security. The access discrimination logic unit combines the "Execute" control access signal from a microprocessor with a signal designating the microprocessor source (e.g. external or internal) to define the type of memory access requested and transfers a control enabling signal as a function of the state of the selected stored access control bit indicating if the requested access is allowed to the addressed block.
Patent FI-954960-A0 (FI)
Inventor: LEISSE MARTIN
IPC: C07C7/08
Filed: 1995-10-18
Abstract: The production of high purity benzene and high purity toluene is obtained by utilizing the initial gas separating column for the treatment of the aromatic containing starting material as a separating column for separating a benzene rich from a toluene rich component. The benzene rich component is subject directly to distillation while the toluene is subject to predistillation to separate high boiling components and only then to extractive distillation is distilled to separate the high purity benzene from the high purity toluene.
Patent FI-961386-A0 (FI)
Inventor: GRAY ANDREW KEVIN
IPC: C11D3/39
Filed: 1996-03-27
Abstract: PCT No. PCT/GB94/02069 Sec. 371 Date Mar. 19, 1996 Sec. 102(e) Date Mar. 19, 1996 PCT Filed Sep. 23, 1994 PCT Pub. No. WO95/09226 PCT Pub. Date Apr. 6, 1995Neutral or alkaline thickened aqueous hydrogen peroxide compositions and processes for the production thereof are provided. The compositions are thickened with a polymeric thickener comprising a polyethylene backbone, with pendant carboxylate groups and pendant groups of the formula -(OCH2CH2)m(OCHXCHY)n-O-R, where m is a position integer, n is zero or a positive integer, X and Y are independently selected from hydrogen atoms, methyl and ethyl groups and R is a hydrophobic group comprising eight or more carbon atoms; and one or more surfactants selected from the group consisting of alcohol ethyoxylates, alkylbenzenesulphonates comprising ten or more carbon atoms, alkylsulphates comprising six or more carbon atoms, alcohol ether sulphates, alpha-sulphoesters and alkylglucosides.
Patent FI-961425-A0 (FI)
Inventor: VASSILAKIS DESPINA
IPC: C08L33/08
Filed: 1996-03-29
Abstract: PCT No. PCT/FR94/01138 Sec. 371 Date Aug. 13, 1996 Sec. 102(e) Date Aug. 13, 1996 PCT Filed Sep. 29, 1994 PCT Pub. No. WO95/09220 PCT Pub. Date Apr. 6, 1995Additive composition enhancing the low temperature operability of average distillates beyond -20 DEG  C. comprising at least 40% by weight of a composition consisting of: i) from 60 to 94% by weight of an antisedimentation additive resulting from the reaction of at least one aliphatic dicarboxylic compound and one polyamine of general formula (II) wherein R is a saturated aliphatic radical comprising from 1 to 32 carbon atoms, n is 2-4 and m is 1-4; and ii) 6-40 % by weight of a dispersing-stabilizing additive having a molecular weight varying from 15000 to 50000 resulting from the esterification reaction of a linear alcohol having from 6 to 24 atoms with an organic acid such as maleic acid and its halides, the ester obtained being polymerized with itself or a copolymerizing compound selected from aliphatic dicarboxylic compounds.
Patent FI-961809-A0 (FI)
Inventor: EVENDEN JOHN LESLIE
IPC: C07D413/04
Filed: 1996-04-26
Abstract: 3-amino-5-carbamoylchromans and 8-fluoro-3-amino-5-carbamoylchromans, as well as enantiomers and salts thereof, are disclosed. Pharmaceutical compositions containing the compounds as active ingredients are also disclosed. The compounds are useful in the treatment of 5-hydroxytryptamine-mediated disorders of the central nervous system.
Patent FI-965077-A0 (FI)
Inventor: WOODINGS CALVIN ROGER
IPC: D04H1/498
Filed: 1996-12-17
Abstract: PCT No. PCT/GB95/01441 Sec. 371 Date Dec. 20, 1996 Sec. 102(e) Date Dec. 20, 1996 PCT Filed Jun. 19, 1995 PCT Pub. No. WO95/35043 PCT Pub. Date Dec. 28, 1995Cigarette filters are disclosed which comprise entangled continuous filaments of lyocell. The filaments may be entangled for example by hydroentangling a web which comprises one or more layers of lyocell filaments in spread tow form or by directing radial or circumferential water jets at a tow of lyocell filaments in rod form.
Patent FI-973492-A0 (FI)
Inventor: GIACOMONI PAOLO
IPC: A61K8/38
Filed: 1997-08-26
Abstract: The use of an effective amount of at least one nitric oxide synthase inhibitor in a cosmetic composition or for making a pharmaceutical composition is disclosed, said inhibitor or pharmaceutical composition being intended to reduce the skin irritant effect of topically applied cosmetic or pharmaceutical substances. A cosmetic or pharmaceutical composition containing an effective amount of at least one nitric oxide synthase inhibitor, and a cosmetic treatment method using said cosmetic composition, are also disclosed.
Patent IL-60114-A0 (IL)
Title: Pharmaceutical compositions for transdermal application in the form of a polyacrylate film
IPC: A61K9/70
Filed: 1980-05-19
Abstract: This invention is directed to a pharmaceutical preparation for transdermal application, which comprises a film comprising a skin-compatible polyacrylate, which swells in water and a pharmaceutically active substance in amorphous form. The invention is also directed to the preparation of said pharmaceutical preparation and its use in administering pharmaceutically active substances.
Patent IL-65915-A0 (IL)
Title: Method for producing a purified immunologically active tryptic peptide and tryptic peptides prepared thereby
IPC: C12P21/00
Filed: 1982-05-31
Abstract: A tryptic peptide is produced by partial tryptic digestion of purified, high molecular size colon-specific antigen-p (CSAp), to produce a lower molecular size antigen carrying the CSAp antigenic determinant. The tryptic peptide is used to produce monospecific anti-CSAp antibodies.
Patent IL-69758-A0 (IL)
Title: 1-phenyl-2(1h,3h)-indolone derivatives and pharmaceutical compositions containing them
IPC: C07D209/34
Filed: 1983-09-18
Abstract: Certain substituted 1-phenyl-3-(aminoalkylidene)-2(1H,3H)-indolones are highly potent gabaergic agents, valuable in the treatment of individuals suffering from schizophrenia or reversing the side effects of a previously or concurrently administered neuroleptic agent; or in the treatment of epilepsy. A wider class of substituted 1-phenyl-3-(aminoalkylidene)-2(1H,3H)-indolones, together with 1-phenyl-3-(2-pyrrolidinylidene)-2(1H,3H)-indolones, and homologs thereof, are valuable in the treatment of anxiety.
Patent IL-87762-A0 (IL)
Title: Heat treatment of metallic workpieces
IPC: C21D1/773
Filed: 1988-09-15
Abstract: A process for heat treatment of metallic workpieces by heating in a vacuum furnace followed by quenching in a coolant gas under above-atmospheric pressure and with coolant-gas circulation.
Patent IL-88630-A0 (IL)
Title: Molding apparatus for ground meat and the like
IPC: A22C7/00
Filed: 1988-12-08
Abstract: A molding apparatus particularly adapted to be associated to a meat chopper to mold the extruded ground meat into hamburgers. The said apparatus is provided with a feeler or sensor (27) which disactivates the meat chopper when a hamburger has been formed and which re-activates said meat chopper when the emptied mold (1) is re-introduced into the formation chamber (4). The feeler or sensor is mounted on the housing or body of the meat chopper so as to be self-adjustable as to its spacing from the formation mold when the positioning of the molding apparatus of the invention changes due to the wear of the meat chopper knives.
Patent IL-92321-A0 (IL)
Title: Process for preparing 63-carboxyamides of teicoplanin antibiotics
IPC: C07K7/64
Filed: 1989-11-15
Abstract: The present invention is directed to an improved process for preparing 63 carboxyamides of teicoplanin (eventually having <1><5>-N-alkyl substituents) by reacting a teicoplanin like compound with an activated ester forming reagent to give an ester function which is substituted by an amine, by contacting an excess of said amine in an organic polar solvent at a temperature comprised between 5 DEG C and 60 DEG C.
Patent IL-98970-A0 (IL)
Title: Cyclopentane derivatives,processes for the preparation thereof and pharmaceutical compositions containing the same
IPC: C07C59/46
Filed: 1991-07-26
Abstract: The invention relates to cyclopentane derivatives of formula (I) and their salts with physiologically tolerables bases and the $g(a), $g(b) or $g(g)-cyclodextrin clathrates and the liposome-encapsulated compounds of formula (I), a process for producing them and their pharmaceutical use.
Patent FI-20000751-A0 (FI)
Inventor: ALA-LUUKKO SAMI
IPC: H04W12/06
Filed: 2000-03-31
Abstract: The invention relates to telecommunications systems, in which a subscriber is identified in a network with a first identifier and with a second identifier in a server providing services to the subscriber through the network. In the invention the first identifier is changed (3-3) in a message to be transferred to the server to a second identifier before transferring the message to the server. Thus the message received from the network can be associated with a particular subscriber in the server.
Patent FI-20025018-A0 (FI)
Inventor: AHONEN PETRI
IPC: H04K1/02
Filed: 2002-04-23
Abstract: The invention concerns a system in a digital wireless data communication network for arranging end-to-end encryption in which the data communication network two or more pieces of terminal equipment are communicating with one another, including at least means for management of encryption parameters (TEK, IV), an encryption key stream generator, means for encrypting a dataflow and for decrypting the encryption with the generated key stream segment (KSS, IV), and wherein at least one of the pieces of terminal equipment is adapted to function as a special server terminal device, which manages and distributes encryption parameters and encryption and/or synchronization applications to the other pieces of terminal equipment based on an established criterion and in the terminal equipment are arranged functionalities and means for downloading, saving, managing and carrying out the applications.
Patent FI-20065698-A0 (FI)
Inventor: HAEMAELAEINEN JYRI
IPC: H04W72/08
Filed: 2006-11-06
Abstract: There is provided a radio system, having a receiver for receiving cell measurement data with respect to an own cell and adjacent cells of each user terminal of a plurality of cells of the radio system; a calculation unit for comparing resulting interference values of different user terminal combinations within the same frequency-time resource group of the radio system on the basis of the cell measurement data, the frequency-time resource group including user terminals of more than one cell; and a processing unit for controlling resource allocation in at least part of the frequency-time resource groups on the basis of the comparison.
Patent IL-103388-A0 (IL)
Title: Benzo-and pyridopyridazinones and pyridazinthiones,their preparation and pharmaceutical compositions containing them
IPC: C07D237/32
Filed: 1992-10-08
Abstract: Benzo or pyridopyridazinones and pyridazinthiones of formula (I) wherein: X and Y are nitrogen or carbon, provided that at least one is carbon, and Z is oxygen or sulfur; R<1> is hydrogen, lower alkyl, aryl, heteroaryl, or heterocycle lower alkylene; R<2>, R<3>, R<4>, R<5> and R<6> are independently selected from hydrogen, lower alkyl, halo, carboxy, alkoxycarbonyl, carbamoyl, acyl, acyl halide, thiomethyl, trifluoromethyl, cyano or nitro; or a pharmaceutically acceptable ester, ether or salt thereof, have been found to be useful as an anti-inflammatory, antiasthmatic, immunosuppressive, anti-allograft rejection, anti-graft-vs-host rejection, autoimmune disease or analgetic agent(s).
Patent IL-108284-A0 (IL)
Title: Use of riluzole for the treatment of parkinson's disease and parkinsonian syndromes
IPC: A61K9/00
Filed: 1994-01-06
Abstract: PCT No. PCT/FR94/00003 Sec. 371 Date Jun. 6, 1995 Sec. 102(e) Date Jun. 6, 1995 PCT Filed Jan. 3, 1994 PCT Pub. No. WO94/15601 PCT Pub. Date Jul. 21, 1994This invention relates to an application of riluzole or the pharmaceutically acceptable salts in the preparation of drugs for the treatment of Parkinson's disease and parkinsonian syndromes.
Patent IL-125694-A0 (IL)
Title: Method and apparatus for integration of a wireless communication system with a cable t.v. system
IPC: H04W52/04
Filed: 1997-02-06
Abstract: The present invention is a method and apparatus for integrating a personal communication system with a cable television plant. A set of radio antenna devices (RAD) are connected to the cable plant. The RADs provide frequency conversion and power control of signal received from the cable plant for wireless transmission to the remote units. The RADs also provide power control and frequency conversion of wireless signals received from the remote units for transmission by the RADs onto the cable plant. In addition to the functions of standard base stations and centralized controller, the CATV base station must also compensate for gain variations in the cable plant. The downstream power control is regulated by a RAD reference signal which can be hidden within the CDMA signal for maximum efficiency. The upstream power control is regulated by an upstream gain reference signal which is individually transmitted by each RAD on the upstream link. The architecture of the present invention lends itself to a great deal of flexibility. Each RAD can operate as either an element of a distributed antenna or a base station sector unto itself. The function of each RAD as distributed antenna or as sector can be remotely programmed from the headend processor. Thus the capacity density of the system can be changed to accommodate the changing traffic density. The flexibility also is important at system deployment. When the system is deploy, the entire system may feed only one sector at the base station thus reducing the start-up cost of implementing a system. As system traffic increases, more resources can simply be added at the headend to provide more capacity.
Patent IL-129386-A0 (IL)
Title: Process for selective derivatization of taxanes
IPC: C07F/
Filed: 1998-08-17
Abstract: A process is described for converting the C(7) hydroxy group of a 10-acyloxy-7-hydroxytaxane to an acetal or ketal, the process comprising treating the 10-acyloxy-7-hydroxytaxane with a ketalizing agent in the presence of an acid catalyst to form a C(7) ketalized taxane of the formula or wherein either X<sup>31</sup> or X<sup>32</sup> represents the 10-acyloxy-7-hydroxytaxane moiety and the other of X<sup>31</sup> and X<sup>32</sup> as well as X<sup>33</sup> and X<sup>34</sup> are independently hydrocarbyl, substituted hydrocarbyl or heteroaryl moieties. Taxanes having a ketalized C(7) hydroxy group are also described.
Patent IL-130764-A0 (IL)
Title: Projectile or warhead
IPC: F42B12/34
Filed: 1997-12-22
Abstract: Projectiles or war-heads with an inner arrangement for the formation of bulging zones (4,4a) are proposed, comprised of an enclosed bulging medium (1) which is terminal-ballistically substantially ineffective and is radially enclosed by a penetration material (2) which is terminal-ballistically effective, with the bulging medium (1) having a lower density as compared with the enclosing penetration material (2). This leads to the effect that on impact or on penetrating a target plate (3) the bulging medium (1) remains behind relative to the encompassing terminal-ballistic effective body (2) and is laterally increasingly bulged by the bulging material (1) which continues to flow in from behind. As a result of the high pressures, a conical (crowned) pressure and bulging zone (4,4a) is formed dynamically, which zone radially widens or fragments the passing ambient effective material (5,5a).
Patent IL-133411-A0 (IL)
Title: Nucleic acid sequence analysis
IPC: G01N33/53
Filed: 1998-07-24
Abstract: The invention relates to the use of a nucleotide in a method for sequencing a polynucleotide, wherein the nucleotide comprises a blocking group at the 3' position and at the terminal phosphate group of the triphosphate chain, wherein the blocking groups are removable by monochromatic light of different wavelengths.
Patent IL-134096-A0 (IL)
Title: Echo cancelling optical microphone
IPC: H04R23/00
Filed: 2000-01-18
Abstract: The invention provides an echo-cancelling system for an optical microphone, for eliminating acoustical echoes from a source of acoustical signals to which the microphone is connected, the system including a source of light for illuminating the acoustical membrane; a photodetector for receiving light reflected from the membrane and for producing output signals; means for supplying power to the source of light; a preamplifier for amplifying the output signals; an input terminal for receiving electrical signals from the source of acoustical signals; a time delay circuit for receiving signals from the source of acoustical signals, and a circuit for regulating the amplitude of the delayed electrical signals, connected between the delay circuit and the source of light, for changing the current supplied to the source of light by the light source power means. <IMAGE>